|
시장보고서
상품코드
1149862
관절내 점성보충 시장 : 치료법별, 용도별, 지역별 - 규모, 점유율, 전망, 기회 분석(2022-2030년)Viscosupplementation Market, by Treatment, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
관절내 점성보충은 관절 통증을 경감하고, 골관절염 관절의 기능 상태를 개선하는 치료법입니다. 이것은 히알루론산이라는 농후한 액체를 무릎에 주사하는 것입니다. 히알루론산(HA)은 활액에 포함되어 연골의 표면을 윤활하게 하고, 관절을 충격으로부터 지키는 기능이 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어 설명
제2장 시장의 전망
- 리포트 내용
- 시장의 정의와 범위
- 주요 요약
- 시장 스냅숏 : 치료법별
- 시장 스냅숏 : 애플리케이션별
- 시장 스냅숏 : 지역별
- COM(Coherent Opportunity Map)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 시장 기회
- 영향 분석
- 시장 동향
- 최근 동향
- 인수와 파트너십 시나리오
- 기술 개요
- 법규제 시나리오
- PEST 분석
제4장 세계의 관절내 점성보충 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 수급에 대한 영향
- 시장에 대한 COVID-19의 영향
제5장 세계의 관절내 점성보충 시장 : 치료법별, 2017-2030년
- 싱글 인젝션 치료 사이클
- 3회 주사 치료 사이클
- 5회 주사 치료 사이클
제6장 세계의 관절내 점성보충 시장 : 용도별, 2017-2030년
- 변형성 슬관절증
- 변형성 고관절증
- 기타
제7장 세계의 관절내 점성보충 시장, 지역별, 2017-2030년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카 지역
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동 지역
- GCC
- 이스라엘
- 기타 중동 지역
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카
제8장 경쟁 구도
- Anika Therapeutics Inc
- Seikagaku Corporation
- Ferring Pharmaceuticals
- Bioventus
- Fidia Farmaceutici S.P.A.
- Mylan N.V.
- Sanofi S.A.
- ORTHOGENRX
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
제9장 섹션
- 조사 방법
- Coherent Market Insights 소개
Viscosupplementation is a treatment that helps in reducing the joint pain, and improves the functional condition of the osteoarthritic joint. It involves the injection of a thick fluid called hyaluronic acid into the knee. Hyaluronic acid (HA) is found in the synovial fluid that lubricates the cartilage surfaces and protects the joints from shock. It greases joints so that bones can move freely and discomfort is reduced. People with osteoarthritis have reduced levels of hyaluronic acid in their joints, which causes pain. The injected gel acts as a cushion and greases up the joints. Hyaluronic acid binds to a variety of proteins, allowing it to make ligaments resistant to pressure. Osteoarthritis is the most common type of arthritis characterized by loss of function and degeneration of cartilage and tissues that cover the ends of the bones in a joint.
Market Dynamics
The increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced disorders, and advancements in the development of hyaluronic acid-based therapies are some of the factors expected to drive the market growth. Increasing adoption of inorganic strategies by key players in market such as acquisitions is expected to drive market growth over the forecast period. Moreover, the onset of the condition is mostly after 30 years of age, which may progress to develop into a disability after 10 years of diagnosis, thus, the rise in geriatrics population in turn, will lead to a rise in the incidence of obesity and osteoarthritis. For instance, according to the WHO (world health organization), as on 4 October, 2021, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2050, the world's population of people aged 60 years and older will be nearly 2.1 billion.
Key features of the study:
- This report provides an in-depth analysis of the global viscosupplementation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market
Detailed Segmentation:
- Global Viscosupplementation Market, By Treatment:
- Single Injection Treatment Cycle
- Three Injection Treatment Cycle
- Five Injection Treatment Cycle
- Global Viscosupplementation Market, By Application:
- Knee Osteoarthritis
- Hip Osteoarthritis
- Others
- Global Viscosupplementation Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Anika Therapeutics Inc*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Seikagaku Corporation
- Ferring Pharmaceuticals
- Bioventus
- Fidia Farmaceutici S.P.A.
- Mylan N.V.
- Sanofi S.A.
- ORTHOGENRX
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Anika Therapeutics Inc*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. Global Viscosupplementation Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Viscosupplementation Market, By Treatment, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Single Injection Treatment Cycle
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Three Injection Treatment Cycle
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Five Injection Treatment Cycle
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Viscosupplementation Market, By Application, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Knee Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Hip Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Viscosupplementation Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Anika Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Seikagaku Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fidia Farmaceutici S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORTHOGENRX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
비교리스트